Tramadol induces changes in Δ-FosB, µ-opioid receptor, and p-CREB level in the nucleus accumbens and prefrontal cortex of male Wistar rat.


Journal

The American journal of drug and alcohol abuse
ISSN: 1097-9891
Titre abrégé: Am J Drug Alcohol Abuse
Pays: England
ID NLM: 7502510

Informations de publication

Date de publication:
2019
Historique:
pubmed: 12 1 2019
medline: 28 3 2020
entrez: 12 1 2019
Statut: ppublish

Résumé

Besides the analgesic effect of tramadol, prolonged exposure to tramadol can induce adaptive changes thereby leading to dependence and tolerance. Tramadol induces its effect via µ-opioid receptor (MOR). However, tramadol has other targets such as serotonin and epinephrine transporters. CREB and ΔFosB are transcriptional factors, which are involved in the behavioral abnormalities underlying drug abuse. In this study, the effects of acute and chronic tramadol treatments on MOR, ΔFosB, and CREB levels were studied. For this purpose, 36 male Wistar rats were used. The animals were divided into two main groups. A total of 18 animals received tramadol (0, 5, and 10 mg/kg) acutely and 18 animals received the same doses for the following 14 days. One hour after the last injection, the NAC and PFC were dissected and kept at -80°C in liquid nitrogen. Using western blotting technique, the levels of MOR, ΔFosB, and p-CREB were evaluated. In the NAC, acute tramadol exposure increases the levels of MOR and p-CREB. Moreover, chronic tramadol administration in this region results in elevated levels of MOR, ΔFosB and p-CREB compared with saline-treated rats. The levels of MOR and p-CREB in the PFC increased in both acute and chronic tramadol exposure. Also, ΔFosB levels increased only following chronic tramadol administration. The results revealed that adaptive changes occurred during drug exposure. We concluded that both CREB and ΔFosB played a role in tramadol dependence. Additionally, increased MOR levels during tramadol treatments might be due to receptor desensitization.

Sections du résumé

BACKGROUND
Besides the analgesic effect of tramadol, prolonged exposure to tramadol can induce adaptive changes thereby leading to dependence and tolerance. Tramadol induces its effect via µ-opioid receptor (MOR). However, tramadol has other targets such as serotonin and epinephrine transporters.
OBJECTIVE
CREB and ΔFosB are transcriptional factors, which are involved in the behavioral abnormalities underlying drug abuse. In this study, the effects of acute and chronic tramadol treatments on MOR, ΔFosB, and CREB levels were studied.
METHODS
For this purpose, 36 male Wistar rats were used. The animals were divided into two main groups. A total of 18 animals received tramadol (0, 5, and 10 mg/kg) acutely and 18 animals received the same doses for the following 14 days. One hour after the last injection, the NAC and PFC were dissected and kept at -80°C in liquid nitrogen. Using western blotting technique, the levels of MOR, ΔFosB, and p-CREB were evaluated.
RESULTS
In the NAC, acute tramadol exposure increases the levels of MOR and p-CREB. Moreover, chronic tramadol administration in this region results in elevated levels of MOR, ΔFosB and p-CREB compared with saline-treated rats. The levels of MOR and p-CREB in the PFC increased in both acute and chronic tramadol exposure. Also, ΔFosB levels increased only following chronic tramadol administration. The results revealed that adaptive changes occurred during drug exposure.
CONCLUSION
We concluded that both CREB and ΔFosB played a role in tramadol dependence. Additionally, increased MOR levels during tramadol treatments might be due to receptor desensitization.

Identifiants

pubmed: 30632799
doi: 10.1080/00952990.2018.1529182
doi:

Substances chimiques

Analgesics, Opioid 0
Creb1 protein, rat 0
Cyclic AMP Response Element-Binding Protein 0
Fosb protein, rat 0
Proto-Oncogene Proteins c-fos 0
Receptors, Opioid, mu 0
Tramadol 39J1LGJ30J

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

84-89

Auteurs

Mitra-Sadat Sadat-Shirazi (MS)

a Iranian National Center for Addiction Studies , Tehran University of Medical Sciences , Tehran , Iran.
b Department of Neuroscience, School of Advanced Technologies in Medicine , Tehran University of Medical Sciences , Tehran , Iran.

Nima Babhadi-Ashar (N)

a Iranian National Center for Addiction Studies , Tehran University of Medical Sciences , Tehran , Iran.

Solmaz Khalifeh (S)

c Cognitive and Neuroscience Research Center (CNRC) , Tehran Medical Sciences, Islamic Azad University , Tehran , Iran.

Sarah Mahboubi (S)

b Department of Neuroscience, School of Advanced Technologies in Medicine , Tehran University of Medical Sciences , Tehran , Iran.

Hamid Ahmadian-Moghaddam (H)

a Iranian National Center for Addiction Studies , Tehran University of Medical Sciences , Tehran , Iran.

Mohammad-Reza Zarrindast (MR)

a Iranian National Center for Addiction Studies , Tehran University of Medical Sciences , Tehran , Iran.
d Department of Pharmacology, School of Medicine , Tehran University of Medical Sciences , Tehran , Iran.
e Endocrinology and Metabolism Research Institute , Tehran University of Medical Science , Tehran , Iran.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH